Biologics in Pediatric Psoriasis and Atopic Dermatitis: Revolutionizing the Treatment LandscapeNovember 5, 2020Atopic DermatitisPsoriasis
Influenza Vaccination Recommendations During Use of Select Immunosuppressants for PsoriasisOctober 14, 2020Infectious DiseasesPsoriasis
Risk for Deep Fungal Infections During IL-17 and IL-23 Inhibitor Therapy for PsoriasisOctober 13, 2020Infectious DiseasesPsoriasis
Active Comparator Trial Designs Used to Promote Development of Innovative New MedicationsSeptember 25, 2020AcneAtopic DermatitisPsoriasisRosaceaHealth Policy
Content Analysis of Psoriasis and Eczema Direct-to-Consumer AdvertisementsSeptember 11, 2020PsoriasisDiversity in Medicine
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With PhototherapyAugust 12, 2020Psoriasis
Apremilast and Systemic Retinoid Combination Treatment for Moderate to Severe Palmoplantar PsoriasisAugust 11, 2020Psoriasis
Eczema Herpeticum in a Patient With Hailey-Hailey Disease Confounded by Coexistent PsoriasisJuly 8, 2020PsoriasisInfectious Diseases
Variations in Preference for Topical Vehicles Among Demographic GroupsJuly 8, 2020AcnePsoriasisAtopic Dermatitis
Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics? March 23, 2020COVID-19 UpdatesPsoriasisInfectious DiseasesPsoriatic Arthritis
Human Immunodeficiency Virus Infection in a Hepatitis B Virus–Positive Psoriasis Patient Treated With UstekinumabMarch 11, 2020PsoriasisInfectious Diseases
Efficacy, Safety, and Tolerability of Halobetasol Propionate 0.01%–Tazarotene 0.045% Lotion for Moderate to Severe Plaque Psoriasis in the Hispanic Population: Post Hoc AnalysisMarch 5, 2020Psoriasis
Effect of In-Office Samples on Dermatologists’ Prescribing Habits: A Retrospective ReviewFebruary 6, 2020AcnePsoriasisRosaceaHair & NailsAtopic Dermatitis
